Market Survey on Plant Derived Proteins Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Plant Derived Proteins Market including Industrial Proteins& Enzymes, Therapeutic Proteins., Blood Proteins, and Cell Culture Functional Proteins Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
[273 Pages Report] The global Plant Derived Proteins Market is estimated to reach US$ 105 Mn by the end of 2022. Growing research and development activities for development of more effective drugs and biologic, especially across countries such as India, China, the U.S., and the U.K. is expected to bolster the growth in the market.
Attribute
Details
Plant Derived Proteins Market Estimated Size in 2022
US$ 105 Million
Plant Derived Proteins Market Projected Size in 2029
An exhaustive survey by Future Market Insights (FMI) reveals that the sales in the global plant derived proteins market is projected to exceed US$ 184.3 Mn, rising at a remarkable CAGR of 8.4% over the forecast period 2022-2029.
Based on plant type, the carrot segment is anticipated to exhibit the fastest growth in the market, accounting for more than 46.2% of the plant derived proteins sales by 2022. The plant derived proteins are expected to hold nearly 0.2% of the market share in the global animal and plant based protein market through 2029.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
8.89%
H1, 2022 Projected
8.36%
H1, 2022 Outlook
7.86%
BPS Change - H1, 2022 (O) - H1, 2022 (P)
(-) 50 ↓
BPS Change - H1, 2022 (O) - H1, 2021
(-) 102 ↓
According to Future Market Insights analysis, the global plant derived proteins market expects to drop by 102 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 50 BPS. The market is subject to regulatory dynamics, pricing fluctuations, and licensing of biologics.
The dip in the BPS values for the market is associated with the emergence of the “free-form” anthology in specialty foods which encloses a gluten and soy-free diet. With the establishment of increased customer choice for gluten and soy-free food products, the market for plant derived products observed a decline in the BPS values.
Conversely, plant derived scaffold proteins for research purposes support cell adhesion and proliferation for regenerative medicine and drug screening by forming critical biomatrices. This has supported promising clinical outlooks, and will pose a positive impact upon the market growth.
2014-2021 Plant Derived Proteins Market Outlook in Comparison to 2022-2029 Growth Forecast
The demand in the global plant derived proteins market grew at a CAGR of 7.6% over the past assessment period 2014-2021. Plant derived proteins are estimated to create an absolute dollar opportunity of US$ 105 Mn by the end of 2022.
Plant derived proteins are biologics sourced from tobacco leaves, rice seeds, carrots, and others by molecular farming or cell-culture procedures. These proteins are natural and environmentally sustainable and have significant potential in comparison to other biologics such as microbial and mammalian cells. For instance, the plant derived experimental antibody named ZMapp was reported to be more effective against the Ebola Virus than others.
Hence, advancements in plant expression vectors, glycoengineering, and downstream processing have resulted in increasing use of plants as a superior alternative for biologics production. Driven by this, the sales in the global plant derived proteins are estimated to surpass US$ 184.3 Mn by the end of 2029.
Will the Surging Demand for Advanced Drugs and Biologics Favor Plant Derived Proteins Market Growth?
Rising prevalence of diseases such as diabetes, hepatitis, lymphoma, and Gaucher disease among others across the world has created strong demand for advanced therapeutics. This significant surge in demand for biologics and drugs cannot be met by current production platforms such as microbial and mammalian cells due to their higher cost and limited scalability.
Hence, numerous biopharmaceutical companies are shifting their focus on using animal-free substitutes such as plants owing to their benefit such as eukaryotic protein modification, high scalability, low cost. This is estimated to accelerate the sales of plant derived proteins in the market.
In addition to this, increasing usage of plant derived proteins as raw materials for therapeutic drug production and surging demand for replacement proteins such as insulin and albumin is expected to assist the market to expand at a CAGR of 8.4% over the forecast period 2022-2029.
How is Implementation of Stringent Regulatory Framework Restraining Plant Derived Proteins Market?
Implementation of stringent guidelines and standards for the production of plant derived proteins by regulatory bodies such as European Medicines Agency (EMA) and Food and Drug Administration (FDA) is hampering the sales in the market.
Also, implementation of ban on the plantation of tobacco in certain countries across Europe, increasing inclination towards biosimilar drugs, and rising incidence of allergic reactions to the drugs produced from genetically engineered plants are factors restraining the growth in the plant derived proteins market.
Find your sweet spots for generating winning opportunities in this market.
Country-wise Analysis
Why is the Plant Derived Proteins Market Flourishing in the U.S.?
“Growing Emphasis on Launching Novel Therapeutics to Bolster Plant Derived Proteins Sales”
Future Market Insights states that the U.S. is projected to register the fastest growth in the North America plant derived proteins market over the assessment period.
With increasing demand for novel plant derived proteins and other biologics-based drugs, leading players in the country are increasingly focusing on developing novel therapeutics and vaccines. For instance, iBio, Inc., an American biologics manufacturing company, announced using its advanced FastPharming technologies to develop three novel plant-based biologics, IBIO-100, IBIO-200, and IBIO-201 in October 2020.
A slew of such developments and product launches is estimated to bolster the sales of plant derived proteins in the U.S. market.
What are the Factors Augmenting the India Plant Derived Proteins Market Growth?
“Increasing Burden of Diabetes to Fuel the Demand for Plant Derived Recombinant Proteins”
As per FMI, India, home to a large number of biotechnology and pharmaceutical companies, is estimated to emerge as the most lucrative plant derived proteins market in South Asia between 2022 and 2029.
The incidence of lifestyle diseases such as diabetes is rapidly increasing owing to the growing fast-paced lifestyle and changing eating habits in India. For instance, according to the International Diabetes Federation, around 74.19 million cases of diabetes between ages 20 to 79 were reported across India, exhibiting a 9.6% rate of incidence in 2021.
As plant derived recombinant proteins such as insulin are extensively being used by diabetic patients to maintain their insulin levels, rising burden of diabetes is expected to elevate the demand for plant derived proteins in India market.
Why is the Market for Plant Derived Proteins Expanding in the U.K.?
“Rising Demand for Cosmetic Products to Bolster the Plant Derived Proteins Sales”
The U.K. is anticipated to register robust growth in the plant derived proteins market in Europe during the forecast period 2022-2029, reveals FMI.
Plant derived proteins are gaining immense popularity across the cosmetic industry, owing to their natural, better results, and environmentally-sustainable attributes. On account of this, leading industry players are shifting the preference towards using plant derived proteins from microbial and mammalian cells for the formulation of face creams, serums, and others cosmetic products.
Hence, rapidly increasing demand for cosmetic products on the back of rising emphasis on enhancing facial aesthetics among the population in the U.K. is projected to bolster the sales of plant derived proteins in the market.
Category-wise Insights
Why is the Demand for Plant Derived Proteins Surging in Tobacco Segment?
“Growing Usage in Breast Cancer Treatment Drugs to Accelerate Plant Derived Therapeutic Proteins Demand”
The tobacco segment is estimated to register robust growth, accounting for nearly 39.6% of the plant derived proteins sales through 2022.
Tobacco plant is considered as the ideal host for plant-based engineered proteins owing to its high yield production, rapid plant growth, and ability to produce large amounts of antibodies within 6 to 7 days. In addition to this, increasing use of tobacco derived proteins in breast cancer treatment drugs is favoring sales of plant derives therapeutic proteins in the segment.
Which Platform Registers High Demand in the Market?
“Rising Adoption of Novel Cell Culture Platforms to Favor the Plant Derived Proteins Market Growth”
On the basis of platform, the global plant derived proteins market is segmented into in-vitro cell culture systems, whole plants, and others. FMI estimates that the in-vitro cell culture systems will account for a significant share in the market over the forecast period. Increasing adoption of novel cell culture platforms such as in-vitro cell culture by biopharmaceutical companies for novel drug production is driving the growth in the segment.
In terms of application, the regenerative medicine-therapeutic agents segment is projected to exhibit rapid growth in the global market through 2029. Growing usage of plant derived proteins as therapeutic agents across the cosmetics industry is the primary factor augmenting sales across the segment.
Will the Therapeutic Proteins Demand Continue Rising?
“Therapeutic Proteins Segment to Account for the Maximum Plant Derived Therapeutic Proteins Sales”
Therapeutic proteins demand is likely to grow at a rapid pace, accounting for more than 70% of the plant derived proteins sales from 2022 to 2029 in terms of protein.
Demand for plant derived therapeutics proteins such as monoclonal antibodies and vaccines is rapidly increasing on the back of their efficiency in the treatment of diseases. Hence, they are extensively being used for the production of biologics and drugs for the treatment of diseases such as anemia, hepatitis, cancer, hemophilia, and others, which is in turn, facilitating the growth in the segment.
Why is the Sales of Plant Derived Proteins Rising in the Biopharmaceutical Companies Segment?
“Rising Novel Drug Development Activities to Spur Sales of Plant Derived Proteins”
Among end users, biopharmaceutical companies are projected to continue leading the plant derived proteins market, accounting for over 50% of the demand share by the end of assessment period.
Increasing government support in research and development (R&D) activities for the production of more effective therapeutics drugs and shifting preference on using plant-based biologics owing to their high scalability and low cost are factor augmenting the sales across the segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Competitive Landscape
Key players in the plant derived proteins market are focusing in adoption expansion strategies such as new product launch and product approval to gain competitive edge. Some of the other companies are aiming at collaboration, merger, and acquisition with other players to expand their market share. For instance,
In April 2021, Protalix BioTherapeutics, Inc., an Israeli-based plant-based enzyme manufacturing company, announced receiving Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for its new product pegunigalsidase alfa (PRX–102), a recombinant alpha-Galactosidase-A protein.
Scope Of The Report
Attribute
Details
Forecast Period
2022 to 2029
Historical Data Available for
2014 to 2021
Market Analysis
US$ Million for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa
Key Countries Covered
USA, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa
Key Segments Covered
Plant, Protein, Platform, Application, End User, and Region
What is the current plant derived proteins market value?
The plant derived proteins market is expected to surpass a valuation of US$ 105 Mn in 2022.
At what rate did the sales of plant derived proteins grow in the last assessment period?
The global plant derived proteins market grew at a 7.6% CAGR over the past assessment period 2014-2021.
At what rate will plant derived proteins market grow between 2022 and 2029?
The plant derived proteins market is expected to register remarkable growth, expanding at 8.4% CAGR between 2022 and 2029.
Which is the most lucrative market for plant derived proteins?
North America currently leads the global plant derived proteins market, accounting maximum sales through 2029.
What is the East Asia plant derived proteins market outlook?
South Asia plant derived proteins market will hold a significant share over the assessment period 2022-2029.
Which plant type segment accounts for maximum plant derived proteins sales?
In terms of plant type, the carrot segment is expected to dominate the global plant derived proteins market, accounting for over 46.2% of the revenue share through 2029.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
2.3. Inclusion & Exclusion/Scope/Limitations
3. Key Market Trends
3.1. Key Trends Impacting The Market
3.2. Advancement & Key Development on Market
3.3. Business Level Trends and Market Developments
4. Key Success Factors
4.1. Key Strategies & Developments adopted by the Industry Incumbents
4.2. Product Adoption Rate/Usage Analysis, By Region
4.3. Vs. Application Matrix
4.4. Promotional Strategies, by Key Manufacturers
5. Global Market - Pricing Analysis
5.1. Key Regulations
5.2. Regional Raw Material Prices Analysis
5.3. End Product Prices Vs Raw material Prices
5.4. Regional Pricing Analysis, By End Product
5.5. Global Average Pricing Analysis Benchmark
6. Global Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022–2029
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
6.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.2. Global Healthcare Market Outlook & Size, 2021
7.3. Global Medical Device Market Outlook & Size, 2021
7.4. Parent Market Outlook & Size, 2021
7.5. Forecast Factors - Relevance & Impact
7.5.1. Key Player Annual Growth Rate
7.5.2. Product Cost
7.5.3. Product Availability
7.5.4. Production Demand
7.5.5. Key Market Consolidation Activities
7.6. Value Chain
7.7. Supply-Demand Scenario
7.7.1. Production vs. Consumption Outlook
7.7.2. Region-wise Demand
7.7.3. Potential Growth
7.7.4. Market Size, among others
7.8. Market Dynamics
7.8.1. Drivers
7.8.2. Restraints
7.8.3. Opportunity Analysis
8. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Plant Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Plant Type, 2014 - 2021
8.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Plant Type, 2022 - 2029
8.3.1. Tobacco
8.3.2. Carrot
8.3.3. Rice
8.3.4. Tomato
8.3.5. Maize Plant
8.3.6. Soybean
8.3.7. Safflower
8.3.8. Lettuce
8.3.9. Barley
8.3.10. Others
8.3.11. Others
8.4. Market Attractiveness Analysis By Plant Type
9. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Protein Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Protein Type, 2014 - 2021
9.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Protein Type, 2022 - 2029
9.3.1. Protein Biopolymers
9.3.1.1. Spider Silk Proteins
9.3.1.2. Elastin Like Polypeptides (ELPs)
9.3.1.3. Collagens
9.3.1.4. Others
9.3.2. Industrial Proteins & Enzymes
9.3.2.1. Hydrolases
9.3.2.2. Glycosidases
9.3.2.3. Proteases
9.3.2.4. Others
9.3.3. Therapeutic Proteins
9.3.3.1. Blood Proteins
9.3.3.2. Vaccine Antigens,
9.3.3.3. Monoclonal antibodies (mAbs)
9.3.3.4. Cytokines,
9.3.3.5. Growth factors
9.3.3.6. Growth Hormones
9.3.3.7. Others
9.3.4. Cell Culture Functional Proteins
9.3.4.1. Albumin
9.3.4.2. Transferrin
9.3.4.3. Fibronectin
9.3.4.4. Aprotinin
9.3.4.5. Fetuin
9.3.4.6. Others
9.4. Market Attractiveness Analysis By Protein Type
10. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Platform Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Platform Type, 2014 - 2021
10.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Platform Type, 2022 - 2029
10.3.1. In-vitro Culture System
10.3.1.1. Plant cell suspensions
10.3.1.2. Hairy Roots
10.3.1.3. Moss
10.3.2. Aquatic plants
10.3.2.1. Duckweed
10.3.2.2. Microalgae
10.3.3. Whole plants
10.3.3.1. Stable Transgenic Plants
10.3.3.2. Transient Plants Polyclonal
10.4. Market Attractiveness Analysis By Platform Type
11. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Application, 2014 - 2021
11.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Application, 2022 - 2029
11.3.1. Regenerative Medicine-Therapeutic Agents
11.3.1.1. Primary Cell Based Therapeutic
11.3.1.2. Stem Cell & Progenitor Cell-based Therapeutics
11.3.2. Regenerative Medicine-Functional Material
11.3.3. Cell Culture Application
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2014-2021 and Forecast 2022-2029, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By End User, 2014 - 2021
12.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2021 - 2021
12.3.1. Biopharmaceutical Companies
12.3.1.1. In-vitro Culture System
12.3.1.2. Aquatic plants
12.3.1.3. Whole plants
12.3.2. Academic & Research Institutes
12.3.2.1. In-vitro Culture System
12.3.2.2. Aquatic plants
12.3.2.3. Whole plants
12.3.3. Contract Research Organization (CROs)
12.3.3.1. In-vitro Culture System
12.3.3.2. Aquatic plants
12.3.3.3. Whole plants
12.3.4. Contract Manufacturing Organization (CMOs)
12.3.4.1. In-vitro Culture System
12.3.4.2. Aquatic plants
12.3.4.3. Whole plants
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2014-2021 and Forecast 2022-2029, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Region, 2014 - 2021
13.3. Current Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2021 - 2021
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Middle East and Africa (MEA)
13.3.5. East Asia
13.3.6. South Asia
13.3.7. Oceania
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021
14.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Plant Type
14.4.3. By Protein Type
14.4.4. By Platform Type
14.4.5. By Application
14.4.6. By End User
14.5. Market Attractiveness Analysis
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021
15.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Argentina
15.4.1.4. Rest of Latin America
15.4.2. By Plant Type
15.4.3. By Protein Type
15.4.4. By Platform Type
15.4.5. By Application
15.4.6. By End User
15.5. Market Attractiveness Analysis
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021
16.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. Italy
16.4.1.3. France
16.4.1.4. U.K.
16.4.1.5. Spain
16.4.1.6. BENELUX
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Plant Type
16.4.3. By Protein Type
16.4.4. By Platform Type
16.4.5. By Application
16.4.6. By End User
16.5. Market Attractiveness Analysis
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021
17.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Plant Type
17.4.3. By Protein Type
17.4.4. By Platform Type
17.4.5. By Application
17.4.6. By End User
17.5. Market Attractiveness Analysis
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021
18.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Plant Type
18.4.3. By Protein Type
18.4.4. By Platform Type
18.4.5. By Application
18.4.6. By End User
18.5. Market Attractiveness Analysis
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021
19.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Plant Type
19.4.3. By Protein Type
19.4.4. By Platform Type
19.4.5. By Application
19.4.6. By End User
19.5. Market Attractiveness Analysis
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2014-2021 and Forecast 2022-2029
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2014 - 2021
20.4. Market Size (US$ Mn)& Volume (Units) Forecast By Market Taxonomy, 2022 - 2029
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. South Africa
20.4.1.3. Rest of Middle East and Africa
20.4.2. By Plant Type
20.4.3. By Protein Type
20.4.4. By Platform Type
20.4.5. By Application
20.4.6. By End User
20.5. Market Attractiveness Analysis
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
21. Emerging Countries Market Analysis 2014-2021 and Forecast 2022-2029
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. China Market Analysis
21.2.1. Introduction
21.2.2. Pricing Analysis
21.2.3. PEST Analysis
21.2.4. Market Value Proportion Analysis by Market Taxonomy
21.2.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
21.2.5.1. By Plant Type
21.2.5.2. By Protein Type
21.2.5.3. By Platform Type
21.2.5.4. By Application
21.2.5.5. By End User
21.2.6. China Market - Competition Landscape
21.3. India Market Analysis
21.3.1. Introduction
21.3.2. Pricing Analysis
21.3.3. PEST Analysis
21.3.4. Market Value Proportion Analysis by Market Taxonomy
21.3.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
21.3.5.1. By Plant Type
21.3.5.2. By Protein Type
21.3.5.3. By Platform Type
21.3.5.4. By Application
21.3.5.5. By End User
21.3.6. India Market - Competition Landscape
21.4. Brazil Market Analysis
21.4.1. Introduction
21.4.2. Pricing Analysis
21.4.3. PEST Analysis
21.4.4. Market Value Proportion Analysis by Market Taxonomy
21.4.5. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
21.4.5.1. By Plant Type
21.4.5.2. By Protein Type
21.4.5.3. By Platform Type
21.4.5.4. By Application
21.4.5.5. By End User
21.4.6. Brazil Market - Competition Landscape
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies (Tissue Diagnostics )
22.2. Market Concentration By Tope Players, 2021
22.3. Market Value Share Analysis of Top 10 Players
22.4. Market Presence Analysis
22.4.1. By Regional Market Footprint of Players
22.4.2. Product Footprint by Players
22.4.3. Channel Footprint by Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Pricing Analysis by Competition
23.3. Competition Benchmarking
23.4. Competition Deep pe
23.4.1. Medicago Inc.
23.4.1.1. Company Overview
23.4.1.2. Product Portfolio & Application
23.4.1.3. Product & Sales Footprint
23.4.1.4. SWOT Analysis
23.4.1.5. Strategy Overview
23.4.1.5.1. Marketing Strategy
23.4.1.5.2. Product Strategy
23.4.1.5.3. Channel Strategy
23.4.1.6. Analyst Commentary.
23.4.2. Planet Biotechnology Inc.
23.4.2.1. Company Overview
23.4.2.2. Product Portfolio & Application
23.4.2.3. Product & Sales Footprint
23.4.2.4. SWOT Analysis
23.4.2.5. Strategy Overview
23.4.2.5.1. Marketing Strategy
23.4.2.5.2. Product Strategy
23.4.2.5.3. Channel Strategy
23.4.2.6. Analyst Commentary.
23.4.3. Kentucky Bioprocessing, LLC
23.4.3.1. Company Overview
23.4.3.2. Product Portfolio & Application
23.4.3.3. Product & Sales Footprint
23.4.3.4. SWOT Analysis
23.4.3.5. Strategy Overview
23.4.3.5.1. Marketing Strategy
23.4.3.5.2. Product Strategy
23.4.3.5.3. Channel Strategy
23.4.3.6. Analyst Commentary.
23.4.4. Ventria Bioscience
23.4.4.1. Company Overview
23.4.4.2. Product Portfolio & Application
23.4.4.3. Product & Sales Footprint
23.4.4.4. SWOT Analysis
23.4.4.5. Strategy Overview
23.4.4.5.1. Marketing Strategy
23.4.4.5.2. Product Strategy
23.4.4.5.3. Channel Strategy
23.4.4.6. Analyst Commentary.
23.4.5. Icon Genetics
23.4.5.1. Company Overview
23.4.5.2. Product Portfolio & Application
23.4.5.3. Product & Sales Footprint
23.4.5.4. SWOT Analysis
23.4.5.5. Strategy Overview
23.4.5.5.1. Marketing Strategy
23.4.5.5.2. Product Strategy
23.4.5.5.3. Channel Strategy
23.4.5.6. Analyst Commentary.
23.4.6. PromoCell GmbH
23.4.6.1. Company Overview
23.4.6.2. Product Portfolio & Application
23.4.6.3. Product & Sales Footprint
23.4.6.4. SWOT Analysis
23.4.6.5. Strategy Overview
23.4.6.5.1. Marketing Strategy
23.4.6.5.2. Product Strategy
23.4.6.5.3. Channel Strategy
23.4.6.6. Analyst Commentary.
23.4.7. Agrenvec
23.4.7.1. Company Overview
23.4.7.2. Product Portfolio & Application
23.4.7.3. Product & Sales Footprint
23.4.7.4. SWOT Analysis
23.4.7.5. Strategy Overview
23.4.7.5.1. Marketing Strategy
23.4.7.5.2. Product Strategy
23.4.7.5.3. Channel Strategy
23.4.7.6. Analyst Commentary.
23.4.8. Axol Bioscience Ltd
23.4.8.1. Company Overview
23.4.8.2. Product Portfolio & Application
23.4.8.3. Product & Sales Footprint
23.4.8.4. SWOT Analysis
23.4.8.5. Strategy Overview
23.4.8.5.1. Marketing Strategy
23.4.8.5.2. Product Strategy
23.4.8.5.3. Channel Strategy
23.4.8.6. Analyst Commentary.
24. Assumptions & Acronyms Used25. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Modality
Table 03: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2014–2029, By Energy Type
Table 04: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2014–2029, By End User
Table 05: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Country
Table 07: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 08: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 09: North America Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 10: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 11: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 12: North America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 13: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 14: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 15: Latin America Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 16: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 17: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 18: Latin America Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 19: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 20: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 21: Europe Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 22: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 23: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 24: Europe Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 25: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 26: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 27: East Asia Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 28: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 29: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 30: East Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 31: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 32: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 33: South Asia Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 34: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 35: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 36: South Asia Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 37: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 38: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 39: Oceania Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 40: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 41: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 42: Oceania Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 43: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Country
Table 44: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 45: MEA Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 46: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 47: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 48: MEA Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 49: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 50: China Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 51: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 52: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 53: China Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 54: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 55: India Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 56: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 57: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 58: India Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Table 59: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 60: Brazil Market Volume (‘000 Units) Analysis 2014-2021 and Forecast 2022–2029, By Product Type
Table 61: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Modality
Table 62: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By Energy Type
Table 63: Brazil Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2029, By End User
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Market Volume (‘000 Units), 2014-2021
Figure 02: Global Market Volume (‘000 Units) Forecast, 2022-2029
Figure 03: Global Market: Pricing Analysis (US$/Unit), by Product Type, 2022
Figure 04: Global Market Value Analysis (US$ Mn), 2014-2021
Figure 05: Global Market Value Forecast (US$ Mn), 2022-2029
Figure 06: Global Market Absolute $ Opportunity, 2022 - 2029
Figure 07: Global Market Share Analysis (%), By Product Type, 2022 & 2029
Figure 08: Global Market Y-o-Y Analysis (%), By Product Type, 2022-2029
Figure 09: Global Market Attractiveness Analysis by Product Type, 2022-2029
Figure 10: Global Market Share Analysis (%), By Modality, 2022 & 2029
Figure 11: Global Market Y-o-Y Analysis (%), By Modality, 2022-2029
Figure 12: Global Market Attractiveness Analysis by Modality, 2022-2029
Figure 13: Global Market Share Analysis (%), By Energy Type, 2022 & 2029
Figure 14: Global Market Y-o-Y Analysis (%), By Energy Type, 2022-2029
Figure 15: Global Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 16: Global Market Share Analysis (%), By End User, 2022 & 2029
Figure 17: Global Market Y-o-Y Analysis (%), By End User, 2022-2029
Figure 18: Global Market Attractiveness Analysis by End User, 2022-2029
Figure 19: Global Market Share Analysis (%), By Region, 2022 & 2029
Figure 20: Global Market Y-o-Y Analysis (%), By Country, 2022-2029
Figure 21: Global Market Attractiveness Analysis by Region, 2022-2029
Figure 22: North America Market Value Share, By Product Type, 2022 (E)
Figure 23: North America Market Value Share, By Modality, 2022 (E)
Figure 24: North America Market Value Share, By Energy Type, 2022 (E)
Figure 25: North America Market Value Share, By End User, 2022 (E)
Figure 26: North America Market Value Share, By Country, 2022 (E)
Figure 27: North America Market Value Analysis (US$ Mn), 2014-2021
Figure 28: North America Market Value Forecast (US$ Mn), 2022-2029
Figure 29: North America Market Attractiveness Analysis by Product Type, 2022-2029
Figure 30: North America Market Attractiveness Analysis by Modality, 2022-2029
Figure 31: North America Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 32: North America Market Attractiveness Analysis by End User, 2022-2029
Figure 33: North America Market Attractiveness Analysis by Country, 2022-2029
Figure 34: Latin America Market Value Share, By Product Type, 2022 (E)
Figure 35: Latin America Market Value Share, By Modality, 2022 (E)
Figure 36: Latin America Market Value Share, By Energy Type, 2022 (E)
Figure 37: Latin America Market Value Share, By End User, 2022 (E)
Figure 38: Latin America Market Value Share, By Country, 2022 (E)
Figure 39: Latin America Market Value Analysis (US$ Mn), 2014-2021
Figure 40: Latin America Market Value Forecast (US$ Mn), 2022-2029
Figure 41: Latin America Market Attractiveness Analysis by Product Type, 2022-2029
Figure 42: Latin America Market Attractiveness Analysis by Modality, 2022-2029
Figure 43: Latin America Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 44: Latin America Market Attractiveness Analysis by End User, 2022-2029
Figure 45: Latin America Market Attractiveness Analysis by Country, 2022-2029
Figure 46: Europe Market Value Share, By Product Type, 2022 (E)
Figure 47: Europe Market Value Share, By Modality, 2022 (E)
Figure 48: Europe Market Value Share, By Energy Type, 2022 (E)
Figure 49: Europe Market Value Share, By End User, 2022 (E)
Figure 50: Europe Market Value Share, By Country, 2022 (E)
Figure 51: Europe Market Value Analysis (US$ Mn), 2014-2021
Figure 52: Europe Market Value Forecast (US$ Mn), 2022-2029
Figure 53: Europe Market Attractiveness Analysis by Product Type, 2022-2029
Figure 54: Europe Market Attractiveness Analysis by Modality, 2022-2029
Figure 55: Europe Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 56: Europe Market Attractiveness Analysis by End User, 2022-2029
Figure 57: Europe Market Attractiveness Analysis by Country, 2022-2029
Figure 58: East Asia Market Value Share, By Product Type, 2022 (E)
Figure 59: East Asia Market Value, By Modality, 2022 (E)
Figure 60: East Asia Market Value Share, By Energy Type, 2022 (E)
Figure 61: East Asia Market Value Share, By End User, 2022 (E)
Figure 62: East Asia Market Value Share, By Country, 2022 (E)
Figure 63: East Asia Market Value Analysis (US$ Mn), 2014-2021
Figure 64: East Asia Market Value Forecast (US$ Mn), 2022-2029
Figure 65: East Asia Market Attractiveness Analysis by Product Type, 2022-2029
Figure 66: East Asia Market Attractiveness Analysis by Modality, 2022-2029
Figure 67: East Asia Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 68: East Asia Market Attractiveness Analysis by End User, 2022-2029
Figure 69: East Asia Market Attractiveness Analysis by Country, 2022-2029
Figure 70: South Asia Market Value Share, By Product Type, 2022 (E)
Figure 71: South Asia Market Value Share, By Modality, 2022 (E)
Figure 72: South Asia Market Value Share, By Energy Type, 2022 (E)
Figure 73: South Asia Market Value Share, By End User, 2022 (E)
Figure 74: South Asia Market Value Share, By Country, 2022 (E)
Figure 75: South Asia Market Value Analysis (US$ Mn), 2014-2021
Figure 76: South Asia Market Value Forecast (US$ Mn), 2022-2029
Figure 77: South Asia Market Attractiveness Analysis by Product Type, 2022-2029
Figure 78: South Asia Market Attractiveness Analysis by Modality, 2022-2029
Figure 79: South Asia Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 80: South Asia Market Attractiveness Analysis by End User, 2022-2029
Figure 81: South Asia Market Attractiveness Analysis by Country, 2022-2029
Figure 82: Oceania Market Value Share, By Product Type, 2022 (E)
Figure 83: Oceania Market Value Share, By Modality, 2022 (E)
Figure 84: Oceania Market Value Share, By Energy Type, 2022 (E)
Figure 85: Oceania Market Value Share, By End User, 2022 (E)
Figure 86: Oceania Market Value Share, By Country, 2022 (E)
Figure 87: Oceania Market Value Analysis (US$ Mn), 2014-2021
Figure 88: Oceania Market Value Forecast (US$ Mn), 2022-2029
Figure 89: Oceania Market Attractiveness Analysis by Product Type, 2022-2029
Figure 90: Oceania Market Attractiveness Analysis by Modality, 2022-2029
Figure 91: Oceania Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 92: Oceania Market Attractiveness Analysis by End User, 2022-2029
Figure 93: Oceania Market Attractiveness Analysis by Country, 2022-2029
Figure 94: MEA Market Value Share, By Product Type, 2022 (E)
Figure 95: MEA Market Value Share, By Modality, 2022 (E)
Figure 96: MEA Market Value Share, By Energy Type, 2022 (E)
Figure 97: MEA Market Value Share, By End User, 2022 (E)
Figure 98: MEA Market Value Share, By Country, 2022 (E)
Figure 99: MEA Market Value Analysis (US$ Mn), 2014-2021
Figure 100: MEA Market Value Forecast (US$ Mn), 2022-2029
Figure 101: MEA Market Attractiveness Analysis by Product Type, 2022-2029
Figure 102: MEA Market Attractiveness Analysis by Modality, 2022-2029
Figure 103: MEA Market Attractiveness Analysis by Energy Type, 2022-2029
Figure 104: MEA Market Attractiveness Analysis by End User, 2022-2029
Figure 105: MEA Market Attractiveness Analysis by Country, 2022-2029
Figure 106: China Market Value Analysis (US$ Mn), 2014-2021
Figure 107: China Market Value Forecast (US$ Mn), 2022-2029
Figure 108: India Market Value Analysis (US$ Mn), 2014-2021
Figure 109: India Market Value Forecast (US$ Mn), 2022-2029
Figure 110: Brazil Market Value Analysis (US$ Mn), 2014-2021
Figure 111: Brazil Market Value Forecast (US$ Mn), 2022-2029
